Erscheint 4 Ausgaben pro Jahr
ISSN Druckformat: 0731-8898
ISSN Online: 2162-6537
Indexed in
Regulating RNA Binding Motif 5 Gene Expression− A Novel Therapeutic Target for Lung Cancer
ABSTRAKT
RNA-binding motif protein 5 (RBM5), also known as LUCA-15/H37, is a gene that maps to human chromosome 3p21.3, a critical region that is deleted in a large number of human cancers, of which the majority are lung cancers, and that is predicted to contain one or more tumor suppressor genes (TSGs). RBM5 is a tumor suppressor gene and is most frequently deleted at the earliest stage of lung cancer development. It represents a significant area of recent progress in cancer genomic, cytogenetic, and molecular biological research because of its role in the induction of cell cycle arrest and apoptosis and the regulation of inhibition of in lung cancer metastasis. RBM5 is involved in the suppression of epidermal growth factor receptor (EGFR) expression, thus preventing proliferation, angiogenesis, invasion, and metastasis of lung cancer. In this way it exhibits its tumor suppressive capacity during lung cancer progression. Exploration of RBM5's potential importance in inhibiting tumor metastasis includes downstream players in the RBM5-mediated metastasis suppressor pathway(s). This review highlights the differential expression of the RBM5 tumor suppressor gene which impacts cell proliferation and apoptosis control during lung cancer progression. Regulating RBM5 expression may be a novel therapeutic target for lung cancer.
-
Wang Qiwei, Wang Fang, Zhong Waisheng, Ling Hang, Wang Jixuan, Cui Jie, Xie Tao, Wen Senli, Chen Jie, RNA-binding protein RBM6 as a tumor suppressor gene represses the growth and progression in laryngocarcinoma, Gene, 697, 2019. Crossref
-
Xu Yanling , Su Zhenzhong , Li Junyao , Wang Qi , Meng Guangping , Zhang Yu , Yang Wen , Zhang Jie , Gao Peng , Role of RNA‑binding protein 5 in the diagnosis and chemotherapeutic response of lung cancer (Review), Oncology Letters, 2018. Crossref
-
Deng Biyong, Pan Runsang, Ou Xin, Wang Taizhe, Wang Weiguo, Nie Yingjie, Chen Houping, Mok K. H., LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion, BioMed Research International, 2021, 2021. Crossref
-
Deng Kun, Yao Jingwei, Huang Jialu, Ding Yubo, Zuo Jianhong, Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy, Translational Oncology, 14, 6, 2021. Crossref
-
Malhan Deeksha, Basti Alireza, Relógio Angela, Transcriptome analysis of clock disrupted cancer cells reveals differential alternative splicing of cancer hallmarks genes, npj Systems Biology and Applications, 8, 1, 2022. Crossref